| Title: | PAD4 promotes macrophage migration to aggravate tubulointerstitial injury in diabetic kidney disease |
| Journal: | Molecular Therapy |
| Published: | 6 Oct 2025 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/41054305/ |
| DOI: | https://doi.org/10.1016/j.ymthe.2025.10.009 |
| URL: | https://pmc.ncbi.nlm.nih.gov/articles/PMC12925809/ |
Publication 19284
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Peptidyl arginine deiminase 4 (PAD4) is an enzyme predominantly expressed in myeloid cells, and its role in diabetic kidney disease (DKD) remains unknown. We functionally characterized 48 PADI4 variants identified among 469,779 participants from UK Biobank and examined their associations with renal function. We found that most PADI4 variants cause loss of function, which was significantly associated with a higher estimated glomerular filtration rate. We observed an enhanced PAD4 expression in renal tubulointerstitium among DKD patients and animal models of DKD. Both PAD4 deficiency in macrophages and PAD4 inhibitor GSK484 significantly alleviated renal tubulointerstitial injury by reducing macrophage infiltration in diabetic mice models. Mechanistically, PAD4 interacted with p65 to promote its binding to Cmklr1 promoter and induce the expression of Cmklr1, which led to an enhanced macrophage migration. These findings demonstrate the crucial role of PAD4-mediated macrophage migration in tubulointerstitial injury of DKD.</p>
10 Keywords
- Animals
- Cell Movement
- Diabetic Nephropathies
- Disease Models, Animal
- Female
- Humans
- Macrophages
- Male
- Mice
- Protein-Arginine Deiminase Type 4
18 Authors
- Yunjie Xiong
- Ruolin Li
- Xiangjun Chen
- Chuan Peng
- Qinglian Zeng
- Shuangshuang Zhu
- Furong He
- Jinshan Wu
- Jiangyun Lei
- Miaoyun Chen
- Shiyun Tong
- Yue Sun
- Yong Xu
- Wei Huang
- Shumin Yang
- Qifu Li
- Jinbo Hu
- Linqiang Ma
1 Application
| Application ID | Title |
|---|---|
| 103654 | Environmental and genetic risk factors and target organ damage of resistant hypertension |
Enabling scientific discoveries that improve human health